In the United States, advances in cancer research have dramatically improved outcomes for children diagnosed with cancer. While pediatric cancer remains a devastating diagnosis, approximately 80 percent of children survive their disease. For children...
Margaret Foti, PhD, MD (hc), chief executive officer of the American Association for Cancer Research (AACR), along with other AACR leaders, joined President Joseph R. Biden at a White House event Wednesday as he...
A new kind of blood test could help detect brain cancers at an earlier stage.
Results favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.
As recently as 10 years ago, the words “machine learning” evoked thoughts of sentient robots and fears of the singularity. Now, we trust the complex processes underlying artificial intelligence (AI) with everything from navigation...
Pharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune response in people with melanoma.
A study finds that people aged 20-30 years in the U.S. had the biggest increase in metastatic, early-onset colorectal cancer between 2000 and 2016, and that Blacks and Hispanics may have the highest risk.
The FDA approved the targeted immunotherapy tebentafusp-tebn for certain adult patients with uveal melanoma. The U.S. Food and Drug Administration (FDA) has approved tebentafusp-tebn (Kimmtrak), a fusion protein that acts as an immunotherapy, for...
Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.
Each year in the United States, about 14,480 women are diagnosed with cervical cancer, and about 4,290 women die of the disease. Survivors often face a lifetime of complications, from infertility to pain and bleeding. ...
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More